Ischemic Stroke in Chinese Young Adults
NCT02756494 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-04-29
Summary
Stroke is the fifth leading cause of death in the United States and the leading cause of disability. However, in China, stroke is one of the most frequent causes of death and chronic disability. Ischemic strokes in adults younger than 45 years of age were regarded as a relatively uncommon event in the proportion of \<5% of all ischemic strokes.
Conditions
Interventions
- BIOLOGICAL
-
Ischemic Stroke in Chinese Young Adults
Sponsors & Collaborators
-
Beijing Chao Yang Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2018-04-30
- Completion
- 2018-12-31
More Related Trials
-
Cohort Study for Severe Ischaemic Stroke
NCT03222024 ·Status: COMPLETED
-
Xingnaojing for Moderate-to-severe Acute Ischemic Stroke (XMAS)
NCT02728180 ·Status: UNKNOWN ·Phase: PHASE4
-
SouthErn China REgisTry for Stroke on Traditional Chinese Medicine
NCT03380481 ·Status: UNKNOWN
-
Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke
NCT05559307 ·Status: UNKNOWN ·Phase: PHASE4
-
FMRI in Monitoring Intracerebral Stem Cell Implantation for Chronic Stroke Patients
NCT01249287 ·Status: UNKNOWN
-
Evaluate the Efficacy of Bu-Yang- Huan-Wu Tang(BYHWT)on Ischemic Stroke
NCT02150252 ·Status: UNKNOWN ·Phase: PHASE2
-
Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke
NCT03296618 ·Status: UNKNOWN ·Phase: PHASE1
-
Trial of pRehospital Intervention With trAditional Chinese Medicine for Acute strokE
NCT04275349 ·Status: UNKNOWN
-
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
NCT04415164 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke
NCT01623622 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China
NCT07322835 ·Status: NOT_YET_RECRUITING
-
Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients
NCT00950521 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Young Health Plasma on Acute Stroke
NCT02913183 ·Status: UNKNOWN ·Phase: PHASE2
-
Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults
NCT05113043 ·Status: RECRUITING
-
Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke
NCT06470477 ·Status: NOT_YET_RECRUITING
-
The Screening of Neuroprotective Biomarkers After Acute Ischemic Stroke
NCT05689528 ·Status: COMPLETED
-
Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke
NCT01714167 ·Status: UNKNOWN ·Phase: PHASE1
-
Evidence-based Evaluation of TCM Key Syndrome Differentiation and Treatment for Acute Ischemic Stroke
NCT04199455 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Pharmacokinetics of Multiple Dose of YC-6 in Healthy Subjects
NCT03358901 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluating the Therapeutic Effect of Acupuncture on Acute Ischemic Stroke Patients
NCT02210988 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
NCT01762163 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of LongShengZhi Capsule on Functional Recovery After Acute Ischaemic Stroke (LONGAN)
NCT05277311 ·Status: UNKNOWN ·Phase: NA
-
Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke
NCT00966316 ·Status: COMPLETED ·Phase: PHASE4
-
Non-disabling Ischemic Cerebrovascular Event With Apathy
NCT04917237 ·Status: RECRUITING
-
A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage
NCT06255977 ·Status: RECRUITING ·Phase: PHASE2